Adlai Nortye
杭州, China · Health and Medical
Do your work at Adlai Nortye?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
Adlai Nortye is a global clinical-stage biopharmaceutical company based in North Brunswick, New Jersey and Hangzhou, China, dedicated to transforming deadly cancer into a chronic and eventually curable disease. Leveraging its dual R&D presence, we are pioneering innovative immuno-oncology medicines.
Our mission is to identify and develop differentiated innovative medicines that help people live better, live longer.
Adlai Nortye’s pipeline focuses on two key areas: RAS-targeting therapies, including AN9025 and AN4035, and next-generation cancer immunotherapies, such as AN8025 and AN4005, designed to activate cancer immunity in novel ways. We are committed to advancing patient care through groundbreaking research and development.
Our mission is to identify and develop differentiated innovative medicines that help people live better, live longer.
Adlai Nortye’s pipeline focuses on two key areas: RAS-targeting therapies, including AN9025 and AN4035, and next-generation cancer immunotherapies, such as AN8025 and AN4005, designed to activate cancer immunity in novel ways. We are committed to advancing patient care through groundbreaking research and development.
Contact Details
ir@adlainortye.com
杭州, China
+1
Founded
2016
Company Type
Public Limited Company
Employees
50-100
Categories
Keywords
#生物医药
#制药
Companies teams usually look at after Adlai Nortye
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.